115 related articles for article (PubMed ID: 37284951)
41. Particulate matter 2.5 induces autophagy via inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin kinase signaling pathway in human bronchial epithelial cells.
Liu T; Wu B; Wang Y; He H; Lin Z; Tan J; Yang L; Kamp DW; Zhou X; Tang J; Huang H; Zhang L; Bin L; Liu G
Mol Med Rep; 2015 Aug; 12(2):1914-22. PubMed ID: 25845384
[TBL] [Abstract][Full Text] [Related]
42. Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K/AKT signaling pathway.
Li ZX; Sheng XD; Wang YL; Wen Lv X
Int Immunopharmacol; 2022 Dec; 113(Pt A):109326. PubMed ID: 36252487
[TBL] [Abstract][Full Text] [Related]
43. IL-8 and IP-10 expression from human bronchial epithelial cells BEAS-2B are promoted by Streptococcus pneumoniae endopeptidase O (PepO).
Zou J; Zhou L; Hu C; Jing P; Guo X; Liu S; Lei Y; Yang S; Deng J; Zhang H
BMC Microbiol; 2017 Aug; 17(1):187. PubMed ID: 28836948
[TBL] [Abstract][Full Text] [Related]
44. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.
Jing Y; Liu LZ; Jiang Y; Zhu Y; Guo NL; Barnett J; Rojanasakul Y; Agani F; Jiang BH
Toxicol Sci; 2012 Jan; 125(1):10-9. PubMed ID: 21984483
[TBL] [Abstract][Full Text] [Related]
45. PI3K/AKT, JNK, and ERK pathways are not crucial for the induction of cholesterol biosynthesis gene transcription in intestinal epithelial cells following treatment with the potato glycoalkaloid alpha-chaconine.
Mandimika T; Baykus H; Poortman J; Garza C; Kuiper H; Peijnenburg A
J Agric Food Chem; 2008 Sep; 56(18):8745-52. PubMed ID: 18729378
[TBL] [Abstract][Full Text] [Related]
46. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells.
Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT
Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349
[TBL] [Abstract][Full Text] [Related]
47. γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways.
Hafner A; Obermajer N; Kos J
Biochem J; 2012 Apr; 443(2):439-50. PubMed ID: 22257123
[TBL] [Abstract][Full Text] [Related]
48. Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.
Lee YY; Kim HP; Kang MJ; Cho BK; Han SW; Kim TY; Yi EC
Exp Mol Med; 2013 Nov; 45(11):e64. PubMed ID: 24263233
[TBL] [Abstract][Full Text] [Related]
49. Long-term exposures to low doses of silver nanoparticles enhanced in vitro malignant cell transformation in non-tumorigenic BEAS-2B cells.
Choo WH; Park CH; Jung SE; Moon B; Ahn H; Ryu JS; Kim KS; Lee YH; Yu IJ; Oh SM
Toxicol In Vitro; 2016 Dec; 37():41-49. PubMed ID: 27596524
[TBL] [Abstract][Full Text] [Related]
50. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms.
Su X; Shen Z; Yang Q; Sui F; Pu J; Ma J; Ma S; Yao D; Ji M; Hou P
Theranostics; 2019; 9(15):4461-4473. PubMed ID: 31285773
[No Abstract] [Full Text] [Related]
51. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms underlying fibronectin-induced up-regulation of P2X4R expression in microglia: distinct roles of PI3K-Akt and MEK-ERK signalling pathways.
Tsuda M; Toyomitsu E; Kometani M; Tozaki-Saitoh H; Inoue K
J Cell Mol Med; 2009 Sep; 13(9B):3251-9. PubMed ID: 19298529
[TBL] [Abstract][Full Text] [Related]
53. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
Tandon M; Chen Z; Pratap J
J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
[TBL] [Abstract][Full Text] [Related]
54. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells.
Miethe C; Torres L; Zamora M; Price RS
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):357-366. PubMed ID: 34449178
[TBL] [Abstract][Full Text] [Related]
56. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
57. Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling.
Yang Z; Cai W; Chen Y; Guo Z; Xiao Z; Zhou T; Cheng Y; Xu F
J Immunol Res; 2022; 2022():5211368. PubMed ID: 36254198
[TBL] [Abstract][Full Text] [Related]
58. Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
Renshaw J; Taylor KR; Bishop R; Valenti M; De Haven Brandon A; Gowan S; Eccles SA; Ruddle RR; Johnson LD; Raynaud FI; Selfe JL; Thway K; Pietsch T; Pearson AD; Shipley J
Clin Cancer Res; 2013 Nov; 19(21):5940-51. PubMed ID: 23918606
[TBL] [Abstract][Full Text] [Related]
59. PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.
Alonso N; Diaz Nebreda A; Monczor F; Gutkind JS; Davio C; Fernandez N; Shayo C
Biochim Biophys Acta; 2016 Sep; 1860(9):1998-2007. PubMed ID: 27316323
[TBL] [Abstract][Full Text] [Related]
60. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
